MONOPAR
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds. Its lead compound, Hu-ATN-658, is a novel monoclonal antibody for the potential treatment of several deadly cancers. Hu-ATN-658 targets the urokinase plasminogen activator receptor (uPAR). Cancer Research UK will be conducting Hu-ATN-658’s early development, including a Phase I clinical trial. In 2014, Chandler D. Robinson, Christopher M. Starr, and Andrew P. Mazar founded the company in Wilmette, Illinois.
MONOPAR
Social Links:
Industry:
Biopharma Biotechnology Developer Tools Health Care Therapeutics
Founded:
2014-01-01
Address:
Wilmette, Illinois, United States
Country:
United States
Website Url:
http://www.monopartx.com
Total Employee:
1+
Status:
Active
Contact:
(847) 388-0349
Email Addresses:
[email protected]
Total Funding:
2.11 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Virginia Region Name.com DNS
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NASDAQ:MNPR
Official Site Inspections
http://www.monopartx.com
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
Loading ... 